Rigel Reports Second Quarter 2026 Financial Results
Go back to Rigel Reports Second Quarter 2026 Financial Results| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 48.18 +0.29 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.89 | 52 Week High | $4.38 | |||
| Open | $48.23 | 52 Week Low | $1.88 | |||
| Day High | $48.53 | P/E | N/A | |||
| Day Low | $47.20 | EPS | $-1.12 | |||
| Volume | 204,930 | |||||

